PhRMA gets defensive on eve of new “Dollars for Docs” report

A new edition of the ProPublica “Dollars for Docs” project she wrote:

“…biopharmaceutical companies are not just gatherers of clinical data, they are disseminators of that data, as well. After all, that information can’t help one patient if it doesn’t get to the physician first.”

Oh, this is going to be a fun exchange to follow.


We Welcome Comments. But please note: We will delete comments that include personal attacks, unfounded allegations, unverified facts, product pitches, profanity or any from anyone who doesn't list what appears to be an actual email address. We will also end any thread of repetitive comments. We don't give medical advice so we won't respond to questions asking for it. Please see more on our comments policy.

Dr Joe

September 12, 2011 at 9:43 pm

Funny how the information does not need to get to physicians when the finding is negative about drugs.